Role of obesity in the etiology of deep vein thrombosis and pulmonary embolism: Current epidemiological insights

Seminars in Thrombosis and Hemostasis

Volumn 39, Issue 5, 2013, Pages 533-540

  Braekkan, Sigridk ^a,b,c   Siegerink, Bob ^a   Lijfering, Willemm ^a   Hansen, John Bjarne ^b,c   Cannegieter, Suzannec ^a   Rosendaal, Fritsr ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF TROMSØ   (Norway)

^c UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

obesity; risk factor; venous thrombosis

Indexed keywords

ADIPOCYTOKINE; ESTROGEN; ORAL CONTRACEPTIVE AGENT;

AGE DISTRIBUTION; ANTICOAGULATION; ARTICLE; BODY MASS; CHRONIC INFLAMMATION; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; FIBRINOLYTIC THERAPY; HUMAN; LUNG EMBOLISM; OBESITY; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; SEX DIFFERENCE; VENOUS STASIS;

BODY FAT DISTRIBUTION; BODY MASS INDEX; COMORBIDITY; HUMANS; OBESITY; OVERWEIGHT; RISK ASSESSMENT; RISK FACTORS; VENOUS THROMBOSIS;

EID: 84879087755     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0033-1343355     Document Type: Article

References (97)

1. World Health Organization Obesity and Overweight. Fact sheet No 311. WHO Media centre, May 2012. Available at: http://www.who.int/mediacentre/factsheets/ fs311/en/. Accessed November 5, 2012
2. OECD Health at a Glance: Europe 2010. OECD Publishing, 2010. Available at: http://dx.doi.org/10.1787/health-glance-2010-en. Accessed November 5, 2012
3. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation: 2002; 106 25 3143 3421
4. World Health Organization Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation. WHO Technical Report Series; 894. Geneva; 2000
5. Snell A. The relation of obesity to fatal postoperative pulmonary embolism. Arch Surg: 1927; 15 2 237 244. doi: 10.1001/archsurg.1927. 01130200085006
6. Pomp E. R., le Cessie S., Rosendaal F. R., Doggen C. J. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. Br J Haematol: 2007; 139 2 289 296
7. Lutsey P. L., Virnig B. A., Durham S. B., et al. Correlates and consequences of venous thromboembolism: The Iowa Women's Health Study. Am J Public Health: 2010; 100 8 1506 1513
8. Tsai A. W., Cushman M., Rosamond W. D., Heckbert S. R., Polak J. F., Folsom A. R. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med: 2002; 162 10 1182 1189
9. Holst A. G., Jensen G., Prescott E. Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study. Circulation: 2010; 121 17 1896 1903
10. Brækkan S. K., Hald E. M., Mathiesen E. B., et al. Competing risk of atherosclerotic risk factors for arterial and venous thrombosis in a general population: the Tromso study. Arterioscler Thromb Vasc Biol: 2012; 32 2 487 491
11. Glynn R. J., Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol: 2005; 162 10 975 982
12. Goldhaber S. Z., Grodstein F., Stampfer M. J., et al. A prospective study of risk factors for pulmonary embolism in women. JAMA: 1997; 277 8 642 645
13. Severinsen M. T., Kristensen S. R., Johnsen S. P., Dethlefsen C., Tjonneland A., Overvad K. Anthropometry, body fat, and venous thromboembolism: a Danish follow-up study. Circulation: 2009; 120 19 1850 1857
14. Samama M. M. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med: 2000; 160 22 3415 3420
15. Stein P. D., Beemath A., Olson R. E. Obesity as a risk factor in venous thromboembolism. Am J Med: 2005; 118 9 978 980
16. Abbasi F., Brown B. W. Jr, Lamendola C., McLaughlin T., Reaven G. M. Relationship between obesity, insulin resistance, and coronary heart disease risk. J Am Coll Cardiol: 2002; 40 5 937 943
17. Bergström A., Pisani P., Tenet V., Wolk A., Adami H. O. Overweight as an avoidable cause of cancer in Europe. Int J Cancer: 2001; 91 3 421 430
18. Braekkan S. K., Mathiesen E. B., Njolstad I., Wilsgaard T., Stormer J., Hansen J. B. Family history of myocardial infarction is an independent risk factor for venous thromboembolism: the Tromso study. J Thromb Haemost: 2008; 6 11 1851 1857
19. Wattanakit K., Lutsey P. L., Bell E. J., et al. Association between cardiovascular disease risk factors and occurrence of venous thromboembolism. A time-dependent analysis. Thromb Haemost: 2012; 108 3 508 515
20. Borch K. H., Braekkan S. K., Mathiesen E. B., et al. Anthropometric measures of obesity and risk of venous thromboembolism: the Tromso study. Arterioscler Thromb Vasc Biol: 2010; 30 1 121 127
21. Eichinger S., Hron G., Bialonczyk C., et al. Overweight, obesity, and the risk of recurrent venous thromboembolism. Arch Intern Med: 2008; 168 15 1678 1683
22. Heit J. A., Mohr D. N., Silverstein M. D., Petterson T. M., O'Fallon W. M., Melton L. J. III. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med: 2000; 160 6 761 768
23. Olié V., Zhu T., Martinez I., Scarabin P. Y., Emmerich J. Sex-specific risk factors for recurrent venous thromboembolism. Thromb Res: 2012; 130 1 16 20
24. Romualdi E., Squizzato A., Ageno W. Abdominal obesity and the risk of recurrent deep vein thrombosis. Thromb Res: 2007; 119 6 687 690
25. Rosendaal F. R. Venous thrombosis: a multicausal disease. Lancet: 1999; 353 9159 1167 1173
26. Lijfering W. M., Rosendaal F. R., Cannegieter S. C. Risk factors for venous thrombosis - current understanding from an epidemiological point of view. Br J Haematol: 2010; 149 6 824 833
27. Severinsen M. T., Overvad K., Johnsen S. P., et al. Genetic susceptibility, smoking, obesity and risk of venous thromboembolism. Br J Haematol: 2010; 149 2 273 279
28. Christiansen S. C., Lijfering W. M., Naess I. A., et al. The relationship between body mass index, activated protein C resistance and risk of venous thrombosis. J Thromb Haemost: 2012; 10 9 1761 1767
29. Abdollahi M., Cushman M., Rosendaal F. R. Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use. Thromb Haemost: 2003; 89 3 493 498
30. Braekkan S. K., Borch K. H., Mathiesen E. B., Njolstad I., Wilsgaard T., Hansen J. B. Body height and risk of venous thromboembolism: The Tromso Study. Am J Epidemiol: 2010; 171 10 1109 1115
31. Borch K. H., Nyegaard C., Hansen J. B., et al. Joint effects of obesity and body height on the risk of venous thromboembolism: the Tromso Study. Arterioscler Thromb Vasc Biol: 2011; 31 6 1439 1444
32. El-Galaly T. C., Kristensen S. R., Overvad K., Steffensen R., Tjonneland A., Severinsen M. T. Interaction between blood type, smoking and factor V Leiden mutation and risk of venous thromboembolism: a Danish case-cohort study. J Thromb Haemost: 2012; 10 10 2191 2193
33. Ohira T., Cushman M., Tsai M. Y., et al. ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). J Thromb Haemost: 2007; 5 7 1455 1461
34. Wolpin B. M., Kabrhel C., Varraso R., et al. Prospective study of ABO blood type and the risk of pulmonary embolism in two large cohort studies. Thromb Haemost: 2010; 104 5 962 971
35. Hernán M. A., Taubman S. L. Does obesity shorten life? The importance of well-defined interventions to answer causal questions. Int J Obes (Lond): 2008; 32 03 S8 S14
36. Ray J. G., Lonn E., Yi Q., et al. HOPE-2 investigators Venous thromboembolism in association with features of the metabolic syndrome. QJM: 2007; 100 11 679 684
37. Borch K. H., Braekkan S. K., Mathiesen E. B., et al. Abdominal obesity is essential for the risk of venous thromboembolism in the metabolic syndrome: the Tromso study. J Thromb Haemost: 2009; 7 5 739 745
38. Steffen L. M., Cushman M., Peacock J. M., et al. Metabolic syndrome and risk of venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology. J Thromb Haemost: 2009; 7 5 746 751
39. Virchow R. Thrombose und Embolie (1846-1856). Leipzig, Germany Verlag von Johann Ambrosius Barth: 1910
40. Fronek A., Criqui M. H., Denenberg J., Langer R. D. Common femoral vein dimensions and hemodynamics including Valsalva response as a function of sex, age, and ethnicity in a population study. J Vasc Surg: 2001; 33 5 1050 1056
41. Sugerman H., Windsor A., Bessos M., Wolfe L. Intra-abdominal pressure, sagittal abdominal diameter and obesity comorbidity. J Intern Med: 1997; 241 1 71 79
42. Willenberg T., Schumacher A., Amann-Vesti B., et al. Impact of obesity on venous hemodynamics of the lower limbs. J Vasc Surg: 2010; 52 3 664 668
43. Després J. P., Lemieux I. Abdominal obesity and metabolic syndrome. Nature: 2006; 444 7121 881 887
44. Reitsma P. H., Rosendaal F. R. Activation of innate immunity in patients with venous thrombosis: the Leiden Thrombophilia Study. J Thromb Haemost: 2004; 2 4 619 622
45. Quist-Paulsen P., Naess I. A., Cannegieter S. C., et al. Arterial cardiovascular risk factors and venous thrombosis: results from a population-based, prospective study (the HUNT 2). Haematologica: 2010; 95 1 119 125
46. Zacho J., Tybjaerg-Hansen A., Nordestgaard B. G. C-reactive protein and risk of venous thromboembolism in the general population. Arterioscler Thromb Vasc Biol: 2010; 30 8 1672 1678
47. Hald E. M., Brækkan S. K., Mathiesen E. B., et al. High-sensitivity C-reactive protein is not a risk factor for venous thromboembolism: the Tromso study. Haematologica: 2011; 96 8 1189 1194
48. Tsai A. W., Cushman M., Rosamond W. D., et al. Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med: 2002; 113 8 636 642
49. Christiansen S. C., Naess I. A., Cannegieter S. C., Hammerstrom J., Rosendaal F. R., Reitsma P. H. Inflammatory cytokines as risk factors for a first venous thrombosis: a prospective population-based study. PLoS Med: 2006; 3 8 e334
50. Vormittag R., Hsieh K., Kaider A., et al. Interleukin-6 and interleukin-6 promoter polymorphism (-174) G > C in patients with spontaneous venous thromboembolism. Thromb Haemost: 2006; 95 5 802 806
51. Berg A. H., Scherer P. E. Adipose tissue, inflammation, and cardiovascular disease. Circ Res: 2005; 96 9 939 949
52. Ouchi N., Parker J. L., Lugus J. J., Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol: 2011; 11 2 85 97
53. Chen Y. J., Zhang L. Q., Wang G. P., et al. Adiponectin inhibits tissue factor expression and enhances tissue factor pathway inhibitor expression in human endothelial cells. Thromb Haemost: 2008; 100 2 291 300
54. Tilg H., Moschen A. R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol: 2006; 6 10 772 783
55. Nakata M., Yada T., Soejima N., Maruyama I. Leptin promotes aggregation of human platelets via the long form of its receptor. Diabetes: 1999; 48 2 426 429
56. Singh P., Peterson T. E., Barber K. R., et al. Leptin upregulates the expression of plasminogen activator inhibitor-1 in human vascular endothelial cells. Biochem Biophys Res Commun: 2010; 392 1 47 52
57. Beltowski J. Leptin and atherosclerosis. Atherosclerosis: 2006; 189 1 47 60
58. Wallace A. M., McMahon A. D., Packard C. J., et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation: 2001; 104 25 3052 3056
59. Allison M. A., Cushman M., Callas P. W., Denenberg J. O., Jensky N. E., Criqui M. H. Adipokines are associated with lower extremity venous disease: the San Diego population study. J Thromb Haemost: 2010; 8 9 1912 1918
60. McTiernan A., Wu L., Chen C., et al. Women's Health Initiative Investigators Relation of BMI and physical activity to sex hormones in postmenopausal women. Obesity (Silver Spring): 2006; 14 9 1662 1677
61. Rosendaal F. R., Van Hylckama Vlieg A., Tanis B. C., Helmerhorst F. M. Estrogens, progestogens and thrombosis. J Thromb Haemost: 2003; 1 7 1371 1380
62. VanWijk M. J., VanBavel E., Sturk A., Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res: 2003; 59 2 277 287
63. Piccin A., Murphy W. G., Smith O. P. Circulating microparticles: pathophysiology and clinical implications. Blood Rev: 2007; 21 3 157 171
64. Owens A. P. III, Mackman N. Microparticles in hemostasis and thrombosis. Circ Res: 2011; 108 10 1284 1297
65. Morel O., Toti F., Hugel B., et al. Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol: 2006; 26 12 2594 2604
66. Goichot B., Grunebaum L., Desprez D., et al. Circulating procoagulant microparticles in obesity. Diabetes Metab: 2006; 32 1 82 85
67. Bucciarelli P., Martinelli I., Artoni A., et al. Circulating microparticles and risk of venous thromboembolism. Thromb Res: 2012; 129 5 591 597
68. Chirinos J. A., Heresi G. A., Velasquez H., et al. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol: 2005; 45 9 1467 1471
69. Bowles L. K., Cooper J. A., Howarth D. J., Miller G. J., MacCallum P. K. Associations of haemostatic variables with body mass index: a community-based study. Blood Coagul Fibrinolysis: 2003; 14 6 569 573
70. Tosetto A., Missiaglia E., Gatto E., Rodeghiero F. The VITA project: phenotypic resistance to activated protein C and FV Leiden mutation in the general population. Vicenza Thrombophilia and Atherosclerosis. Thromb Haemost: 1997; 78 2 859 863
71. de Visser M. C., Rosendaal F. R., Bertina R. M. A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis. Blood: 1999; 93 4 1271 1276
72. Koster T., Blann A. D., Briët E., Vandenbroucke J. P., Rosendaal F. R. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet: 1995; 345 8943 152 155
73. Landin K., Stigendal L., Eriksson E., et al. Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism: 1990; 39 10 1044 1048
74. Meltzer M. E., Lisman T., de Groot P. G., et al. Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1. Blood: 2010; 116 1 113 121
75. Meltzer M. E., Bol L., Rosendaal F. R., Lisman T., Cannegieter S. C. Hypofibrinolysis as a risk factor for recurrent venous thrombosis; results of the LETS follow-up study. J Thromb Haemost: 2010; 8 3 605 607
76. Lisman T., de Groot P. G., Meijers J. C., Rosendaal F. R. Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis. Blood: 2005; 105 3 1102 1105
77. Rosito G. A., D'Agostino R. B., Massaro J., et al. Association between obesity and a prothrombotic state: the Framingham Offspring Study. Thromb Haemost: 2004; 91 4 683 689
78. Mavri A., Stegnar M., Krebs M., Sentocnik J. T., Geiger M., Binder B. R. Impact of adipose tissue on plasma plasminogen activator inhibitor-1 in dieting obese women. Arterioscler Thromb Vasc Biol: 1999; 19 6 1582 1587
79. Folsom A. R., Qamhieh H. T., Wing R. R., et al. Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults. Arterioscler Thromb: 1993; 13 2 162 169
80. Robert S. A., Reither E. N. A multilevel analysis of race, community disadvantage, and body mass index among adults in the US. Soc Sci Med: 2004; 59 12 2421 2434
81. Isma N., Merlo J., Ohlsson H., Svensson P. J., Lindblad B., Gottsäter A. Socioeconomic factors and concomitant diseases are related to the risk for venous thromboembolism during long time follow-up. J Thromb Thrombolysis: 2012
82. Enga K. F., Brækkan S. K., Hansen-Krone I. J., Hansen J. B. Emotional states and future risk of venous thromboembolism: the Tromso Study. Thromb Haemost: 2012; 107 3 485 493
83. Rosengren A., Fredén M., Hansson P. O., Wilhelmsen L., Wedel H., Eriksson H. Psychosocial factors and venous thromboembolism: a long-term follow-up study of Swedish men. J Thromb Haemost: 2008; 6 4 558 564
84. Zöller B., Li X., Sundquist J., Sundquist K. Socioeconomic and occupational risk factors for venous thromboembolism in Sweden: a nationwide epidemiological study. Thromb Res: 2012; 129 5 577 582
85. Zöller B., Li X., Sundquist J., Sundquist K. Autoimmune diseases and venous thromboembolism: a review of the literature. Am J Cardiovasc Dis: 2012; 2 3 171 183
86. Steffen L. M., Folsom A. R., Cushman M., Jacobs D. R. Jr, Rosamond W. D. Greater fish, fruit, and vegetable intakes are related to lower incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology. Circulation: 2007; 115 2 188 195
87. Bhoopat L., Rojnuckarin P., Hiransuthikul N., Intragumtornchai T. Low vegetable intake is strongly associated with venous thromboembolism in Thai population. Blood Coagul Fibrinolysis: 2010; 21 8 758 763
88. Varraso R., Kabrhel C., Goldhaber S. Z., Rimm E. B., Camargo C. A. Jr. Prospective study of diet and venous thromboembolism in US women and men. Am J Epidemiol: 2012; 175 2 114 126
89. Hansen-Krone I. J., Enga K. F., Njolstad I., Hansen J. B., Braekkan S. K. Heart healthy diet and risk of myocardial infarction and venous thromboembolism. The Tromso Study. Thromb Haemost: 2012; 108 3 554 560
90. Lutsey P. L., Steffen L. M., Virnig B. A., Folsom A. R. Diet and incident venous thromboembolism: the Iowa Women's Health Study. Am Heart J: 2009; 157 6 1081 1087
91. Fitzgerald K. C., Chiuve S. E., Buring J. E., Ridker P. M., Glynn R. J. Comparison of associations of adherence to a Dietary Approaches to Stop Hypertension (DASH)-style diet with risks of cardiovascular disease and venous thromboembolism. J Thromb Haemost: 2012; 10 2 189 198
92. Lindqvist P. G., Epstein E., Olsson H. The relationship between lifestyle factors and venous thromboembolism among women: a report from the MISS study. Br J Haematol: 2009; 144 2 234 240
93. van Stralen K. J., Le Cessie S., Rosendaal F. R., Doggen C. J. Regular sports activities decrease the risk of venous thrombosis. J Thromb Haemost: 2007; 5 11 2186 2192
94. Borch K. H., Hansen-Krone I., Braekkan S. K., et al. Physical activity and risk of venous thromboembolism. The Tromso study. Haematologica: 2010; 95 12 2088 2094
95. van Stralen K. J., Doggen C. J., Lumley T., et al. The relationship between exercise and risk of venous thrombosis in elderly people. J Am Geriatr Soc: 2008; 56 3 517 522
96. Carroll C., Miller D. Health, the Science of Human Adaptation. 4th ed. Dubuque W. C. Brown Company Publishers: 1986
97. Virchow R. Phlogose und Thrombose im Gefäßsystem: Gesammelte Abhandlungen zur Wissenschaftlichen Medizin. Frankfurt, Germany Österreichische Staatsdruckerei: 1856